For pharmaceutical companies, going up against David Frederick of Kellogg Huber Hansen Todd Evans & Figel at the U.S. Supreme Court has been a bitter pill — until Tuesday.
Fortified by a strong oral argument from Kathleen Sullivan of Quinn Emanuel Urquhart & Sullivan last October, and some interesting recusal actions by the justices, Wyeth LLC pulled off a major 6-2 win in a battle against Frederick over vaccine liability in the case of Bruesewitz v. Wyeth .
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
